MeiraGTx Holdings (MGTX) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$397.5M

Revenue (quarter)

$321.4M

Revenue growth (year over year)

+8608.59%

Gross profit (trailing twelve months)

$389.4M

Gross margin

97.95%

Net income (trailing twelve months)

$78.9M

Net income (quarter)

$160.7M

Net income growth (year over year)

+514.15%

Net margin

19.86%

Return on equity

72.28%

EPS (trailing twelve months)

$0.89

Book value per share

$2.29

P/E (trailing twelve months)

12.70

Price to book

4.65

Debt to assets

45.57%

Payout ratio

—

Dividend yield

—

Company profile

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

• Is MeiraGTx Holdings (MGTX) profitable?

  Yes. MeiraGTx Holdings earned $78.9M in net income over the trailing twelve months, a net margin of 19.86%.

• How much revenue does MeiraGTx Holdings (MGTX) make?

  MeiraGTx Holdings generated $397.5M in revenue over the trailing twelve months, up 8608.59% year over year.

• What is MGTX's P/E ratio?

  MeiraGTx Holdings trades at 12.7 times trailing twelve-month earnings, on an EPS of $0.89.

• How do I buy stock in MeiraGTx Holdings (MGTX)?

  MGTX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.